Optimi Health OPTH
NASDAQ OPTH
$2.25 +0.02 (+0.90%)
At close: Nov 13, 2026 · 4:00 PM EST

Optimi Health (OPTH) Return on Capital Employed [ROCE] (2025 - 2026)

Updated

Optimi Health's Return on Capital Employed [ROCE] came in at -89.61% for the quarter ended Jun 30, 2026, up 20.81 percentage points from -110.42% a year earlier and up 78.56 percentage points from the prior quarter.

Analysis

Optimi Health (OPTH) Return on Capital Employed [ROCE] (2025 - 2026) Analysis & Trends

For the year ended Sep 30, 2025, Optimi Health's Return on Capital Employed [ROCE] was -77.40%, down 28.70 percentage points from the prior year.

  • Going back by year, Return on Capital Employed [ROCE] was -48.70% in the year ended Sep 30, 2024.
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -168.17% (the quarter ended Mar 31, 2026) to -80.20% (the quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Optimi Health 9.67 Mn -791,462.39 112,839.24 -89.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -89.61%
Mar 31, 2026 -168.17%
Sep 30, 2025 -80.20%
Jun 30, 2025 -110.42%
API Access

Optimi Health Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OPTH&period=max&api_key=YOUR_API_KEY